Multiple Myeloma, drug therapy

Name
Multiple Myeloma, drug therapy
Accession Number
DBCAT003831
Description

Not Available

Drugs
DrugDrug Description
LucatumumabInvestigated for use/treatment in leukemia (lymphoid), multiple myeloma, and lymphoma (unspecified).
IsatuximabA chimeric monoclonal antibody targeted against surface CD38 glycoproteins for the treatment of multiple myeloma in patients who have failed previous therapies.
Drugs & Drug Targets
DrugTargetType
LucatumumabTumor necrosis factor receptor superfamily member 5target
IsatuximabADP-ribosyl cyclase 1target